课题基金 / 基金详情

Development of Pharmaceutical Additives-Evaluation of Protein and Polysaccharide Hydrolysates as Carrier to Enhance Absorption Rate of Drug

Development of Pharmaceutical Additives-Evaluation of Protein and Polysaccharide Hydrolysates as Carrier to Enhance Absorption Rate of Drug
药物添加剂的开发-蛋白质和多糖水解物作为载体提高药物吸收率的评价
批准号:
07557146
负责人:
OTAGIRI Masaki
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997

项目摘要

项目成果

OTAGIRI Masaki的其他基金

相似基金

相关文献

中文摘要
翻译
蛋白质和多糖如水溶性明胶、蛋清蛋白、酪蛋白水解物、低分子壳聚糖和海藻酸盐是各种药物制剂中首选的药物载体。然而,使用天然聚合物改善药物的溶出和吸收还没有得到充分的研究。因此,本研究旨在探讨酪蛋白水解物、蛋清蛋白等天然聚合物作为增溶剂改善难溶药物吸收的可能性。1)利用腐植酸酶和Na2S从水牛的角和蹄中制备了两种碎裂角蛋白(FKS),并考察了它们在小鼠体内的理化和生物药理性质。FKS的全身急性毒性明显低于超氧化物歧化酶。在血浆中,酶解角蛋白的速度很慢,但在肝和肾的匀浆中,它的Hydr…略快一些。更多的溶解。相反,碎裂的明胶在所用的任何介质中都没有被水解。2)在蛋清的存在下,dl-a-生育酚(VE)的溶解度增加了300倍。卵白蛋白固体分散体中VE的表观溶出度明显高于单独VE。口服蛋清蛋白固体分散体,尤其是含有肉豆蔻酸的蛋清蛋白固体分散体后,VE的平均血药浓度显著高于单独给药。3)用酶解酪蛋白制备了酪蛋白A(平均肽长3.3)和酪蛋白B(平均肽长17.4)两种酪蛋白水解物,并考察了它们对药物体外溶出度和口服生物利用度的影响。三种药物(双氯芬酸、安定、强的松龙)与酪蛋白A、B混合捏合后的体外溶出行为较单用药物显著改善。血药浓度-时间曲线表明,强的松龙在酪蛋白A捏合液和强的松龙溶液中均能迅速完全吸收。此外,与强的松龙粉相比,强的松龙与酪蛋白B捏合的混合物在给药后1小时内更难被吸收。较少
英文摘要
Protein and polysaccharides such as water-soluble gelatin, egg albumin, casein hydrolysate, low molecular chitosan and alginate are the preferred carriers of drugs in various pharmaceutical formulations. However, improvents of the dissolution and absorption of drugs using natural polymers have been not fully studied. Thus, the present study was undertaken to investigate the possible use of natural polymers such as casein hydrolysate, egg albumin as solubilizing agents to improve the absorption of poorly water soluble drugs. The results obtained here are summarized as follows :1)Two types of fragmented keratin (FKs) were prepared from buffalo horn and hoof using savinase and Na_2S,and their physicochemical and biopharmaceutical properties were examined in mice. The systematic acute toxicity of FKs was significantly lower than that of superoxide dismutase. In plasma, enzymatically fragmented keratin was hydrolyzed slowly, but in liver and kidney homogenates it showed slightly faster hydr … More olysis. In contrast, fragmented gelatin was not hydrolyzed in any of the media used here.2)The solubility of dl-a-tocopherol (VE) was increased by 300-fold in the presence of egg albumin. The apparent dissolution rate of VE from solid dispersion with egg albumin was markedly enhanced in comparison with VE alone. The mean serum levels of VE following oral administration of egg albumin solid dispersions, especially egg albumin solid dispersion containing myristic acid, were significantly higher than those of the drug alone.3)Two types of casein hydrolysates, casein A (mean peptide length 3.3) and casein B (mean peptide length 17.4) were prepared by the enzymatic hydrolysis of casein, and their effects on in vitro dissolution rates and oral bioavailability of drugs were evaluated. The in vitro dissolution behavior of the kneaded mixture of three drugs (diclofenac acid, diazepam, and prednisolone) with caseins A and B were significantly improved compared to the drugs alone. The plasma concentration-time profile showed that prednisolone was completely and rapidly absorbed from the casein A kneaded mixture as well as the prednisolone solution. In addition, prednisolone in the kneaded mixture with casein B was more difficult to absorb up to 1 hr after administration in comparison to prednisolone powder. Less
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
今井 輝子、小田切 優樹(他3名): "Casein Hydrolysate as a Rapid and/or Enteric Dissoluing Additive for Oral Drugs" Pharmaceutical Development and Technology. 3.2(in press). (1998)
Teruko Imai、Yuki Odagiri(以及其他 3 人):“酪蛋白水解物作为口服药物的快速和/或肠溶添加剂”药物开发和技术 3.2(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Otagiri Masaki et al: "Casein Hydrolysate as a Rapid and / or Enteric Dissoluing Additive for Oral Drugs" Pharmaceutical Development and Technology. 3.2. (1998)
Otagiri Masaki 等人:“酪蛋白水解物作为口服药物的快速和/或肠溶添加剂”药物开发和技术。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
今井輝子,小田切優樹(他4名): "Mutual Effect of Egg Albuin and Fatty Acid on Bioacaility of dl-α-Tocopherol" Int.J.Pharm.(1997)
Teruko Imai、Yuki Odagiri(以及其他 4 人):“鸡蛋白蛋白和脂肪酸对 dl-α-生育酚生物活性的相互影响”Int.J.Pharm.(1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Fathy、小田切 優樹(他3名): "Preparation and Evaluation of Beads of Different Calcium Alginate Composition for Oral Sustained Relase of Tiaramide" Pharmaceutical Development and Technology. (in press). (1998)
M.Fathy、Yuki Odagiri(以及其他 3 人):“用于 Tiaramide 口服持续释放的不同海藻酸钙组合物的制备和评估”药物开发和技术(1998 年出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 30 条
    Development of novel hybrid anti-oxidant based on albumin fusion technology and its therapeutic application on acute radiation syndrome
    • 批准号:
      15K15008
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2015
    • 负责人:
      OTAGIRI Masaki
    • 依托单位:
    Construction of an Innovative Bone Marrow Delivery System of Anticancer Drug for Control of Malignant Tumors' Bone Metastasis
    • 批准号:
      25670085
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      OTAGIRI Masaki
    • 依托单位:
    Design and Evaluation of Next Generation Albumin-thioredoxin Fusion Protein for Multiple Organ Failure Treatment
    • 批准号:
      24390043
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.06万
    • 财政年份:
      2012
    • 负责人:
      OTAGIRI Masaki
    • 依托单位:
    Development of effective blood purification treatment method usingHSA bound toxic comnpodus designed bpyhase display tecnohlogy
    • 批准号:
      23659088
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      OTAGIRI Masaki
    • 依托单位:
    海外基金